Correction: Clinical features and associated factors of intraocular inflammation following intravitreal brolucizumab as switching therapy for neovascular age‑related macular degeneration
1 Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan.
2 Division of Ophthalmology, Department of Surgery, Kobe University Graduate School of Medicine, 7‑5‑2, Kusunoki‑Cho, Chuo‑Ku, Kobe, 650‑0017, Japan. [email protected].
3 Department of Ophthalmology, Kakogawa Central City, Hospital, Kakogawa, Japan.